News & Events

32 Biosciences Companies (Gateway Biome & Covira) offer Simple Agreement for Future Equity (SAFE) investment opportunities. The SAFE agreements for Gateway Biome and Covira terms $1.0M each for company, $0.1M minimum, 20% discount, Valuation Caps Gateway Biome $7.5M and Covira $22.5M. (Dec 2023)

The University of Chicago and Gateway Biome file provisional patent application for Compositions, Kits, and Methods for Assessing Microbiome Health (File Date: Dec 12, 2023)

Gut Microbes. 2023 Jan-Dec;15 “Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity” Eugene B Chang, Et al (Jan-Dec 2023)

bioRxiv. 2023 Oct 17 “Bile acid fitness determinants of a Bacteroides fragilis isolate from a human pouchitis patient” Eugene B Chang, Et al (Oct 2023)

Am J Physiol Gastrointest Liver Physiol 2023 Sep 27 “Altered Hepatic and Intestinal Homeostasis in a Neonatal Murine Model of Short-Term Total Parenteral Nutrition and Antibiotics” Joseph F Pierre, Et al (Sept 2023)

bioRxiv. 2023 Sep 26 “Microbially-catalyzed conjugation of GABA and tyramine to bile acids” Eugene B Chang, Et al (Sept 2023)

J Clin Invest. 2023 Sep 15 “Gut microbes and the liver circadian clock partition glucose and lipid metabolism” Eugene B Chang, Et al (Sept 2023)

Cell Rep. 2023 Aug 29 “Dynamic genetic adaptation of Bacteroides thetaiotaomicron during murine gut colonization” Eugene B Chang, Et al (Aug 2023)

Semin Nephrol. 2023 Aug 22 “Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease” Joseph F Pierre, Et al (Aug 2023)

Science. 2023 Aug 4 “Peptide YY: A Paneth cell antimicrobial peptide that maintains Candida gut commensalism” Eugene B Chang, Joseph F Pierre, Et al (Aug 2023)

medRxiv. 2023 Jun 22 “The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newborns” Joseph F Pierre, Et al (June 2023)

Am J Physiol Heart Circ Physiol. 2023 Jun 1 “The TMEM43 S358L mutation affects cardiac, small intestine, and metabolic homeostasis in a knock-in mouse model” Joseph F Pierre, Et al (June 2023)

Cell. 2023 Apr 27 “Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment” Joseph F Pierre, Et al (April 2023)

mSystems. 2023 Apr 27 “Erratum for Proctor et al., "Resources To Facilitate Use of the Altered Schaedler Flora (ASF) Mouse Model To Study Microbiome Function"“ Joseph F Pierre, Et al (April 2023)

bioRxiv. 2023 Mar 25 “A highly conserved and globally prevalent cryptic plasmid is among the most numerous mobile genetic elements in the human gut” Eugene B Chang, Et al (Mar 2023)

Front Immunol. 2023 Jan 31 “TRPV6 deficiency attenuates stress and corticosterone-mediated exacerbation of alcohol-induced gut barrier dysfunction and systemic inflammation” Joseph F Pierre, Et al (Jan 2023)

bioRxiv. 2023 Jan 9 “Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model” Eugene B Chang, Et al (Jan 2023)

The University of Chicago and Gateway Biome file patent application

Gateway Biome signs consulting agreement with Eva Garland Consulting and kicks-off project to secure grants (non-dilutive capital) for research & development. (Jan 2023)

Gateway Biome hires Chief Executive Officer Peter Farmakis; LinkedIn Article (Jan 2022)

Gateway Biome, Inc, a spinout from the University of Chicago, is established (November 2022)